Expression of bcl-2 in fetal tissues suggests a role in morphogenesis. DP LeBrun, RA Warnke, ML Cleary The American journal of pathology 142 (3), 743, 1993 | 467 | 1993 |
Chimeric homeobox gene E2A-PBX1 induces proliferation, apoptosis, and malignant lymphomas in transgenic mice DA Dedera, EK Waller, DP LeBrun, A Sen-Majumdar, ME Stevens, ... Cell 74 (5), 833-843, 1993 | 238 | 1993 |
Lymphoid neoplasms in patients with rheumatoid arthritis and dermatomyositis: frequency of Epstein-Barr virus and other features associated with immunosuppression OW Kamel, M van de Rijn, DP LeBrun, LM Weiss, RA Warnke, ... Human pathology 25 (7), 638-643, 1994 | 198 | 1994 |
Growth fraction estimation of malignant lymphomas in formalin-fixed paraffin-embedded tissue using anti-PCNA/Cyclin 19A2. Correlation with Ki-67 labeling. OW Kamel, DP LeBrun, RE Davis, GJ Berry, RA Warnke The American journal of pathology 138 (6), 1471, 1991 | 195 | 1991 |
bcl-2 expression in primary malignancies of the skin CRJ Morales-Ducret, M van de Rijn, DP LeBrun, BR Smoller Archives of dermatology 131 (8), 909-912, 1995 | 160 | 1995 |
The transcription factor encyclopedia D Yusuf, SL Butland, MI Swanson, E Bolotin, A Ticoll, WA Cheung, ... Genome biology 13, 1-25, 2012 | 141 | 2012 |
Topographical dissociation of BCL-2 messenger RNA and protein expression in human lymphoid tissues CM Chleq-Deschamps, DP LeBrun, P Huie, DP Besnier, RA Warnke, ... | 141 | 1993 |
Follicular lymphomas of the gastrointestinal tract. Pathologic features in 31 cases and bcl-2 oncogenic protein expression. DP LeBrun, OW Kamel, ML Cleary, RF Dorfman, RA Warnke The American journal of pathology 140 (6), 1327, 1992 | 141 | 1992 |
Transformation properties of the E2a-Pbxl chimeric oncoprotein: fusion with E2a is essential, but the Pbxl homeodomain is dispensable K Monica, DP Lebrun, DA Dedera, R Brown, ML Cleary Molecular and Cellular Biology, 1994 | 134 | 1994 |
Fusion with E2A alters the transcriptional properties of the homeodomain protein PBX1 in t (1; 19) leukemias DP LeBrun, ML Cleary Oncogene 9 (6), 1641-1647, 1994 | 122 | 1994 |
bcl‐2 expression reliably distinguishes trichoepitheliomas from basal cell carcinomas BR Smoller, M Van de Rijn, D Lebrun, RA Warnke British Journal of Dermatology 131 (1), 28-31, 1994 | 107 | 1994 |
E2A-PBX1 interacts directly with the KIX domain of CBP/p300 in the induction of proliferation in primary hematopoietic cells R Bayly, L Chuen, RA Currie, BD Hyndman, R Casselman, GA Blobel, ... Journal of Biological Chemistry 279 (53), 55362-55371, 2004 | 88 | 2004 |
Inactivation of the CDKN2A tumor-suppressor gene by deletion or methylation is common at diagnosis in follicular lymphoma and associated with poor clinical outcome A Alhejaily, AG Day, HE Feilotter, T Baetz, DP LeBrun Clinical Cancer Research 20 (6), 1676-1686, 2014 | 72 | 2014 |
FLI-1 distinguishes Ewing sarcoma from small cell osteosarcoma and mesenchymal chondrosarcoma AF Lee, MM Hayes, D LeBrun, I Espinosa, GP Nielsen, AE Rosenberg, ... Applied Immunohistochemistry & Molecular Morphology 19 (3), 233-238, 2011 | 68 | 2011 |
E2A basic helix-loop-helix transcription factors in human leukemia DP LeBrun Front Biosci 8, s206-s222, 2003 | 65 | 2003 |
Restricted expression of E2A protein in primary human tissues correlates with proliferation and differentiation MN Rutherford, DP LeBrun The American journal of pathology 153 (1), 165-173, 1998 | 60 | 1998 |
Estimation of tumor growth fractions in archival formalin-fixed, paraffin-embedded tissues using two anti-PCNA/Cyclin monoclonal antibodies. Factors affecting reactivity. AB Gelb, OW Kamel, DP LeBrun, RA Warnke The American journal of pathology 141 (6), 1453, 1992 | 56 | 1992 |
The bcl-2 oncogene in Hodgkin's disease arising in the setting of follicular non-Hodgkin's lymphoma DP LeBrun, BY Ngan, LM Weiss, P Huie, RA Warnke, ML Cleary | 52 | 1994 |
Floral variant of follicular lymphoma: immunological and molecular studies support a neoplastic process JJ Goates, OW Kamel, DP LeBrun, D Benharroch, RF Dorfman The American journal of surgical pathology 18 (1), 37-47, 1994 | 49 | 1994 |
MicroRNA signature obtained from the comparison of aggressive with indolent non-Hodgkin lymphomas: potential prognostic value in mantle-cell lymphoma RS Goswami, EG Atenafu, Y Xuan, L Waldron, PP Reis, T Sun, A Datti, ... Journal of clinical oncology 31 (23), 2903-2911, 2013 | 47 | 2013 |